Powered by
DETROIT—The Barbara Ann Karmanos Cancer Institute, the largest provider of cancer care and research in Michigan and part of McLaren Health Care, announced that the new TheraBionic P1 device, an …
DETROIT–The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D., as the new leader of the Phase 1 Clinical Trials Multidisciplinary Team and co-leader of the Gastrointestinal (GI) and Neuroendocrine …
DETROIT–The Barbara Ann Karmanos Cancer Institute welcomes Morhaf Al Achkar as associate center director for education. Dr. Al Achkar brings over 10 years of experience in education and teaching, research, …
DETROIT–Karmanos Cancer Institute announced that it will be the first provider in the country to offer patients the new FDA-approved TheraBionic P1 device for the treatment of advanced hepatocellular carcinoma …
DETROIT–Discrimination experienced by Black people can affect their health and increase their frailty, which can be particularly impactful for cancer survivors, according to a new study by researchers at Barbara …
DETROIT–The Barbara Ann Karmanos Cancer Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, has become the first cancer center to receive the SoftVue 3D Whole Breast Ultrasound Tomography System following …
DETROIT—Officials at the The Barbara Ann Karmanos Cancer Institute announced that the institute has been awarded a $325,372 grant from U CAN-CER VIVE Foundation. The funds will support cancer research focused on diffuse large …
DETROIT—Officials at the Karmanos Cancer Institute in Detroit have announced the launch of a new clinical trials study information portal (SIP) at www.karmanos.org/opentrials. The SIP website, which is integrated with …
DETROIT—The Barbara Ann Karmanos Cancer Institute announced that Eric A. Brown, M.D., FACS, breast surgeon, has joined its medical team, effective April 20. Board certified in general surgery and breast ultrasound, …
NOVI—The ultrasound breast examination technology being developed by a Novi medical device startup, Delphinus Medical Technologies Inc., has been shown to be predictive of future breast cancers, according to a …